The 5-year analysis of Sandu Pharmaceuticals Ltd's performance infers:
Sandu Pharmaceuticals Ltd earnings have grown by 12%, whereas share price has appreciated 1.5% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.